Navigation Links
Ventas to Present at the Citi 2008 Global Property CEO Conference
Date:2/26/2008

LOUISVILLE, Ky., Feb. 26 /PRNewswire-FirstCall/ -- Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that its Chairman, President and Chief Executive Officer, Debra A. Cafaro, and Executive Vice President and Chief Investment Officer, Raymond J. Lewis, will make a presentation regarding the Company at the Citi 2008 Global Property CEO Conference in Palm Beach, Florida on Tuesday, March 4, 2008 at 1:15 p.m. Eastern Time.

Those wishing to access the presentation may dial in to the conference at 719-234-7878, passcode: 394890. Any written materials accompanying the presentation will be available on the Company's website at http://www.ventasreit.com at the time of the presentation and for one month thereafter.

Ventas, Inc. is a leading healthcare real estate investment trust. Its diverse portfolio of properties located in 43 states and two Canadian provinces includes seniors housing communities, skilled nursing facilities, hospitals and medical office and other properties. More information about Ventas can be found on its website at http://www.ventasreit.com.

Contacts: Debra A. Cafaro

Chairman, President and CEO

or

Richard A. Schweinhart

Executive Vice President and CFO

(502) 357-9000


'/>"/>
SOURCE Ventas, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69
2. Ventas Completes Previously Announced Sale of Common Stock
3. Ventas Enters Agreement to Sell Common Stock
4. Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance
5. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
6. Ventas Appoints Brush SVP - Senior Housing Development and Operations
7. Ventas Announces 2007 Third Quarter Earnings Release Date and Conference Call
8. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
9. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
10. Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference
11. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: